Cargando…
Clinical efficacy and safety of nimotuzumab plus chemotherapy in patients with advanced colorectal cancer: a retrospective analysis
OBJECTIVE: To compare the clinical efficacy and safety of nimotuzumab combined with chemotherapy versus chemotherapy alone as first-line treatment for advanced colorectal cancer (ACRC). METHOD: We retrospectively enrolled patients with ACRC treated with nimotuzumab plus chemotherapy (n = 40) or chem...
Autores principales: | Bai, Sai-xi, Zhang, Ruo-rong, Chen, Wang-hua, Dong, Hong-min, Wang, Gang, Li, Xiao-kai, Wang, Wenling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113702/ https://www.ncbi.nlm.nih.gov/pubmed/31948326 http://dx.doi.org/10.1177/0300060519895858 |
Ejemplares similares
-
Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
por: Song, Xinmao, et al.
Publicado: (2019) -
Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience
por: Xu, Shuping, et al.
Publicado: (2016) -
Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study
por: Liu, Wei, et al.
Publicado: (2022) -
Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
por: Wang, Dong-Xu, et al.
Publicado: (2020) -
Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial
por: Yuan, Jing-Jing, et al.
Publicado: (2022)